Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s share price gapped down prior to trading on Wednesday . The stock had previously closed at $2.72, but opened at $2.55. Curaleaf shares last traded at $2.90, with a volume of 435,790 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Cormark upgraded shares of Curaleaf from a "hold" rating to a "moderate buy" rating in a report on Friday, August 8th.
Check Out Our Latest Analysis on CURLF
Curaleaf Price Performance
The company has a market capitalization of $1.94 billion, a P/E ratio of -9.06 and a beta of 0.69. The company's 50-day moving average price is $1.27 and its two-hundred day moving average price is $1.11. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.47 and a quick ratio of 0.70.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. As a group, sell-side analysts expect that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.
About Curaleaf
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Featured Stories
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.